Biotech · Private company

Ambit Biosciences Corporation

Track this companyFree. Adds Ambit Biosciences Corporation to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid LeukemiaPHASE2 · COMPLETED · started Apr 1, 2012ClinicalTrials.gov NCT01565668 · fetched Nov 12, 2026
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)PHASE1 · COMPLETED · started Apr 1, 2012ClinicalTrials.gov NCT01468467 · fetched Nov 12, 2026
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)PHASE1 · COMPLETED · started Oct 1, 2011ClinicalTrials.gov NCT01390337 · fetched Nov 12, 2026
AC220 for Children With Relapsed/Refractory ALL or AMLPHASE1 · COMPLETED · started Sep 1, 2011ClinicalTrials.gov NCT01411267 · fetched Nov 12, 2026